← Back to Search

Computer Image Analysis for Skin Conditions

N/A
Recruiting
Led By Raja Sivamani, MD, MS, AP
Research Sponsored by Integrative Skin Science and Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial tests if computer images can accurately judge skin conditions.

Who is the study for?
This trial is for adults with acne, rosacea, melasma, or seborrheic dermatitis. Participants must be able to give consent and should not have facial markings like piercings or tattoos that could affect the imaging process on the day of facial photography.Check my eligibility
What is being tested?
The study aims to see if computer-based image grading can accurately assess the severity of skin conditions such as acne, melasma, rosacea, and seborrheic dermatitis compared to expert clinical evaluations.See study design
What are the potential side effects?
Since there are no interventions like medications or procedures being tested in this trial—only image analysis—participants are not expected to experience any direct side effects from participating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation of image-based grading to clinical gradings for acne
Correlation of image-based grading to clinical gradings for melasma
Correlation of image-based grading to clinical gradings for rosacea
+1 more
Secondary outcome measures
Sebum excretion rate

Trial Design

4Treatment groups
Experimental Treatment
Group I: Seborrheic DermatitisExperimental Treatment1 Intervention
Grading of seborrheic dermatitis with Seborrheic Dermatitis Area Severity Index score
Group II: RosaceaExperimental Treatment1 Intervention
Inflammatory lesion count
Group III: MelasmaExperimental Treatment1 Intervention
Pigment intensity and distribution with use of Melasma Area Severity Index
Group IV: Acne vulgarisExperimental Treatment1 Intervention
Inflammatory and non-inflammatory lesion counts

Find a Location

Who is running the clinical trial?

Integrative Skin Science and ResearchLead Sponsor
31 Previous Clinical Trials
1,732 Total Patients Enrolled
Codex LabsUNKNOWN
1 Previous Clinical Trials
34 Total Patients Enrolled
Raja Sivamani, MD, MS, APPrincipal InvestigatorIntegrative Skin and Research

Media Library

Acne vulgaris Clinical Trial Eligibility Overview. Trial Name: NCT05942248 — N/A
Seborrheic Dermatitis Research Study Groups: Acne vulgaris, Rosacea, Melasma, Seborrheic Dermatitis
Seborrheic Dermatitis Clinical Trial 2023: Acne vulgaris Highlights & Side Effects. Trial Name: NCT05942248 — N/A
Acne vulgaris 2023 Treatment Timeline for Medical Study. Trial Name: NCT05942248 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the size of the sample population being enrolled for this research study?

"Affirmative. Clinicaltrials.gov's records indicate that this clinical trial, initially posted on June 6th 2023, is actively enrolling individuals. A total of 1000 patients are needed to be recruited from a single medical centre."

Answered by AI

Is this research endeavor currently accepting participants?

"The clinical trial is still seeking patients, with the initial posting occurring on June 6th 2023 and an update made to it as recently as July 4th 2023. Data for this can be found on clinicaltrials.gov."

Answered by AI

Who else is applying?

What site did they apply to?
Integrative Skin and Research
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria

What questions have other patients asked about this trial?

Do you have to be in the state the trial is based in?
PatientReceived no prior treatments

Why did patients apply to this trial?

I have tried so many different treatment options for melasma and nothing works, and I'd like to help in any research available to combat this condition.
PatientReceived no prior treatments
~545 spots leftby Apr 2025